Related Experiment Video
Updated: Feb 7, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
CRL4DCAF2 negatively regulates IL-23 production in dendritic cells and limits the development of psoriasis
Tao Huang1, Zhengjun Gao1, Yu Zhang2
1Life Sciences Institute, Zhejiang University, Hangzhou, China.
Abstract:
The E3 ligase CRL4DCAF2 is believed to be a pivotal regulator of the cell cycle and is required for mitotic and S phase progression. The NEDD8-targeting drug MLN4924, which inactivates cullin ring-finger ubiquitin ligases (CRLs), has been examined in clinical trials for various types of lymphoma and acute myeloid leukemia. However, the essential role of CRL4DCAF2 in primary myeloid cells remains poorly understood. MLN4924 treatment, which mimics DCAF2 depletion, also promotes the severity of mouse psoriasis models, consistent with the effects of reduced DCAF2 expression in various autoimmune diseases. Using transcriptomic and immunological approaches, we showed that CRL4DCAF2 in dendritic cells (DCs) regulates the proteolytic fate of NIK and negatively regulates IL-23 production. CRL4DCAF2 promoted the polyubiquitination and subsequent degradation of NIK independent of TRAF3 degradation. DCAF2 deficiency facilitated NIK accumulation and RelB nuclear translocation. DCAF2 DC-conditional knockout mice displayed increased sensitivity to autoimmune diseases. This study shows that CRL4DCAF2 is crucial for controlling NIK stability and highlights a unique mechanism that controls inflammatory diseases.
Insights
The E3 ligase CRL4DCAF2 controls NIK stability, impacting cell cycle and inflammatory diseases. Its inhibition worsens autoimmune conditions, revealing a novel therapeutic target.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- The E3 ligase CRL4DCAF2 is crucial for cell cycle regulation.
- NEDD8-targeting drugs like MLN4924, which inhibit cullin ring-finger ubiquitin ligases (CRLs), are in clinical trials for cancers.
- The role of CRL4DCAF2 in myeloid cells and autoimmune diseases is unclear.
Purpose of the Study:
- To investigate the function of CRL4DCAF2 in dendritic cells (DCs).
- To elucidate the mechanism by which CRL4DCAF2 regulates NIK and IL-23 production.
- To determine the role of CRL4DCAF2 in autoimmune disease pathogenesis.
Main Methods:
- Transcriptomic analysis
- Immunological assays
- DCAF2 DC-conditional knockout mouse models
Main Results:
- CRL4DCAF2 in DCs regulates NIK degradation and negatively controls IL-23 production.
- CRL4DCAF2 promotes NIK polyubiquitination and degradation independently of TRAF3.
- DCAF2 deficiency leads to NIK accumulation, RelB nuclear translocation, and increased susceptibility to autoimmune diseases.
Conclusions:
- CRL4DCAF2 is essential for controlling NIK stability.
- CRL4DCAF2 plays a critical role in regulating inflammatory responses.
- This study reveals a novel mechanism for controlling inflammatory diseases via CRL4DCAF2-mediated NIK regulation.
Related Concept Videos
Negative Regulator Molecules
Limiting Reactant
Master Transcription Regulators
pH Regulation in Cells
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
Neurons: The Cell Body and the Dendrites
The Number e as a Limit

